Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Myriad Genetics Inc. (MYGN)

-NasdaqGS

32.93 Down 0.20(0.60%) May 17, 4:00PM EDT|After Hours : 32.98 Up 0.05 (0.15%) May 17, 4:26PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 156,473   149,140   133,437   132,965  
Cost of Revenue20,334  19,884  17,327  16,952  
Gross Profit 136,139   129,256   116,110   116,013  
Operating Expenses
Research Development13,618  14,107  11,400  12,143  
Selling General and Administrative64,603  59,563  56,128  56,584  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 57,918   55,586   48,582   47,286  
Income from Continuing Operations
Total Other Income/Expenses Net1,324  1,399  1,240  1,186  
Earnings Before Interest And Taxes59,242  56,985  49,822  48,472  
Interest Expense -   -   -   -  
Income Before Tax59,242  56,985  49,822  48,472  
Income Tax Expense21,349  21,949  19,686  19,330  
Minority Interest -   -   -   -  
Net Income From Continuing Ops37,893  35,036  30,136  29,142  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 37,893   35,036   30,136   29,142  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 37,893   35,036   30,136   29,142  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.